retatrutide causing diarrhea Unapproved weight loss drug causes extreme side effects Retatrutide: FDA approval time, trial

Now that millions of people are taking these medications far beyond the scope of clinical trials researchers are beginning to understand why

In clinical trials, tirzepatide achieved up to 18% weight loss compared to semaglutide at 12%

A public estimate may refer to a trial context, a non-approved product, or a source that does not follow the same quality standards as regulated prescription channels

Research-Grade Manufacturing: Produced under controlled conditions to support reproducibility across laboratory studies

Because it might be

If you have hyperthyroidism, your provider should ensure your thyroid condition is well-controlled before starting GLP-1 therapy